Related Experiment Video
Updated: Aug 30, 2026

Posterior Semicircular Canal Approach for Inner Ear Gene Delivery in Neonatal Mouse
Published on: March 2, 2018
Assessment of auditory and vestibular function and gene therapy in the Snell's waltzer mouse model of human deafness
Eyal Marton1,2, Roni Hahn1, Lior Bikovski1,3
1Department of Human Genetics & Computational Medicine, Gray Faculty of Medical & Health Sciences and Sagol School of Neuroscience, Tel Aviv University, 6997801, Tel Aviv, Israel.
Abstract:
The Snell's waltzer mouse (Myo6sv/sv) serves as a model for human deafness and vestibular behavioral impairment, caused by a spontaneous 130 bp recessive deletion in the Myo6 gene. In this study, we characterized the auditory and vestibular phenotypes of Myo6sv/sv mice. These mice exhibit profound hearing loss, with cochlear hair cell stereocilia beginning to fuse soon after birth, ultimately leading to disorganization of hair bundles and degeneration of hair cells. Mice also exhibit behavioral phenotypes characterized by severe imbalance, hyperactivity with bouts of circling, and delayed spatial learning of a novel environment, but preserved normal behavioral circadian rhythms. These behaviors emerge in association with the loss of the characteristic staircase morphology of vestibular hair cell stereocilia soon after birth and the subsequent profound elongation of the stereocilia. Adeno-associated virus (AAV) gene replacement therapy, delivered on the day of birth or one day after, failed to restore auditory or vestibular function. Our findings underscore the essential role of Myo6 in the auditory and vestibular systems and imply prenatal intervention may be required for effective therapy.
